Clinical Trial Update: Prognostic Molecular Markers in Patients With Myelodysplastic Syndrome

View source ↗

Summary

This completed clinical trial investigated prognostic molecular markers in patients with myelodysplastic syndrome.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myelodysplastic Syndrome

Snippet

Sponsor: Samsung Medical Center | Conditions: Myelodysplastic Syndrome | Status: COMPLETED